These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34603902)

  • 1. A Systematic Review of the Utility of Bromocriptine in Acute Peripartum Cardiomyopathy.
    Badianyama M; Das PK; Gaddameedi SR; Saukhla S; Nagammagari T; Bandari V; Mohammed L
    Cureus; 2021 Sep; 13(9):e18248. PubMed ID: 34603902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cabergoline treatment promotes myocardial recovery in peripartum cardiomyopathy.
    Pfeffer TJ; Mueller JH; Haebel L; Erschow S; Yalman KC; Talbot SR; Koenig T; Berliner D; Zwadlo C; Scherr M; Hilfiker-Kleiner D; Bauersachs J; Ricke-Hoch M
    ESC Heart Fail; 2023 Feb; 10(1):465-477. PubMed ID: 36300679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy.
    Haghikia A; Podewski E; Berliner D; Sonnenschein K; Fischer D; Angermann CE; Böhm M; Röntgen P; Bauersachs J; Hilfiker-Kleiner D
    Clin Res Cardiol; 2015 Nov; 104(11):911-7. PubMed ID: 26026286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of bromocriptine in peripartum cardiomyopathy: a systematic review and meta-analysis.
    Trongtorsak A; Kittipibul V; Mahabir S; Ibrahim M; Saint Croix GR; Hernandez GA; Chaparro S
    Heart Fail Rev; 2022 Mar; 27(2):533-543. PubMed ID: 34725781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study.
    Sliwa K; Blauwet L; Tibazarwa K; Libhaber E; Smedema JP; Becker A; McMurray J; Yamac H; Labidi S; Struman I; Hilfiker-Kleiner D
    Circulation; 2010 Apr; 121(13):1465-73. PubMed ID: 20308616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of bromocriptine on left ventricular functional recovery in peripartum cardiomyopathy: insights from the BRO-HF retrospective cohort study.
    Tremblay-Gravel M; Marquis-Gravel G; Avram R; Desplantie O; Ducharme A; Bibas L; Pacheco C; Couture E; Simard F; Poulin A; Malhamé I; Tran D; Rey E; Tournoux F; Harvey L; Sénéchal M; Bélisle P; Descarries L; Farand P; Pranno N; Diaz A; Afilalo J; Ly HQ; Fortier A; Jolicoeur EM;
    ESC Heart Fail; 2019 Feb; 6(1):27-36. PubMed ID: 30565890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study.
    Hilfiker-Kleiner D; Haghikia A; Berliner D; Vogel-Claussen J; Schwab J; Franke A; Schwarzkopf M; Ehlermann P; Pfister R; Michels G; Westenfeld R; Stangl V; Kindermann I; Kühl U; Angermann CE; Schlitt A; Fischer D; Podewski E; Böhm M; Sliwa K; Bauersachs J
    Eur Heart J; 2017 Sep; 38(35):2671-2679. PubMed ID: 28934837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolactin Inhibition in Peripartum Cardiomyopathy: Systematic Review and Meta-analysis.
    Kumar A; Ravi R; Sivakumar RK; Chidambaram V; Majella MG; Sinha S; Adamo L; Lau ES; Al'Aref SJ; Asnani A; Sharma G; Mehta JL
    Curr Probl Cardiol; 2023 Feb; 48(2):101461. PubMed ID: 36261102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripartum cardiomyopathy in patients with psychiatric disorders successfully treated with bromocriptine: Two case reports.
    Takanaka H; Ono R; Kato H; Iwahana T; Miyahara T; Takahashi H; Hori Y; Fukushima K; Kobayashi Y
    J Cardiol Cases; 2024 Mar; 29(3):136-139. PubMed ID: 38481642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart failure due to peripartum cardiomyopathy presenting in the first week of puerperium-A case series from Nepal.
    Banmala S; Awal S; Bata L; Adhikari P; Basnet S; Chaudhary B
    Clin Case Rep; 2024 Jun; 12(6):e9043. PubMed ID: 38827942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unveiling the Mystery of Peripartum Cardiomyopathy: A Traditional Review.
    Chinweuba GC; Rutkofsky IH
    Cureus; 2020 Oct; 12(10):e10790. PubMed ID: 33042652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Peripartum Cardiomyopathy].
    Pfeffer TJ; König T; Berliner D; Bauersachs J
    Dtsch Med Wochenschr; 2022 Nov; 147(23):1537-1544. PubMed ID: 36384155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripartum cardiomyopathy in Iraq: initial registry-based data and 6 month outcomes.
    Farhan HA; Yaseen IF
    ESC Heart Fail; 2021 Oct; 8(5):4048-4054. PubMed ID: 34184413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of Randomized Controlled Trials in Patients with Peripartum Cardiomyopathy.
    Mujkanovic J; Qayyum AA
    Curr Cardiol Rev; 2023; 19(2):e230822207933. PubMed ID: 36017853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A global perspective on the management and outcomes of peripartum cardiomyopathy: a systematic review and meta-analysis.
    Hoevelmann J; Engel ME; Muller E; Hohlfeld A; Böhm M; Sliwa K; Viljoen C
    Eur J Heart Fail; 2022 Sep; 24(9):1719-1736. PubMed ID: 35778990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboembolism in peripartum cardiomyopathy: a systematic review.
    Radakrishnan A; Dokko J; Pastena P; Kalogeropoulos AP
    J Thorac Dis; 2024 Jan; 16(1):645-660. PubMed ID: 38410599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy.
    Bauersachs J; König T; van der Meer P; Petrie MC; Hilfiker-Kleiner D; Mbakwem A; Hamdan R; Jackson AM; Forsyth P; de Boer RA; Mueller C; Lyon AR; Lund LH; Piepoli MF; Heymans S; Chioncel O; Anker SD; Ponikowski P; Seferovic PM; Johnson MR; Mebazaa A; Sliwa K
    Eur J Heart Fail; 2019 Jul; 21(7):827-843. PubMed ID: 31243866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy.
    Haghikia A; Podewski E; Libhaber E; Labidi S; Fischer D; Roentgen P; Tsikas D; Jordan J; Lichtinghagen R; von Kaisenberg CS; Struman I; Bovy N; Sliwa K; Bauersachs J; Hilfiker-Kleiner D
    Basic Res Cardiol; 2013 Jul; 108(4):366. PubMed ID: 23812247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripartum cardiomyopathy presenting with predominant left ventricular diastolic dysfunction: efficacy of bromocriptine.
    Ballo P; Betti I; Mangialavori G; Chiodi L; Rapisardi G; Zuppiroli A
    Case Rep Med; 2012; 2012():476903. PubMed ID: 23251175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.